U/EEA: HIV diagnoses rise for the first time in a decade

18143_lores

Source: National Institute of Allergy and Infectious Diseases (NIAID)

The increase in 2022 can be attributed to several factors including restoring surveillance activities, scale-up and introduction of novel testing strategies in many countries, migration patterns, lifting of COVID-19 restrictions and arrival of refugees.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE